Fabio
117 lines
7.8 KiB
Markdown
117 lines
7.8 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Health insurance; requirements for certain opioid antagonists."
|
||
description: "Health insurance; requirements for certain opioid antagonists. Requires each health insurer, corporation providing health care subscription plans, and health maintenance organization whose policy, contract, or plan includes coverage for prescription drugs to include coverage for at least one other opioid antagonist used for overdose reversal dispensed pursuant to an oral, written, or standing order of a prescriber and ensure that cost-sharing for at least one opioid antagonist used for overdose reversal is included on the lowest cost tier of the insurer's, corporation's, or health maintenance organization's prescription drug formulary. The bill provides that such coverage shall be exempt from any prior authorization or step therapy requirement on coverage of benefits. As introduced, this bill was a recommendation of the Joint Commission on Health Care. This bill is identical to SB 257."
|
||
jurisdiction: "us/states/va"
|
||
legislature: "Virginia General Assembly"
|
||
session: "2026"
|
||
identifier: "HB 795"
|
||
citation: "Virginia HB 795 (2026)"
|
||
classification: ["bill"]
|
||
subjects: []
|
||
status: "enacted"
|
||
primary_sponsors: ["Atoosa R. Reaser"]
|
||
version_count: 6
|
||
action_count: 44
|
||
vote_count: 12
|
||
first_action: "2026-01-13"
|
||
last_action: "2026-04-08"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/7977c5bc-31ee-41c0-9783-29e0ea63e355"
|
||
source_url: "https://lis.virginia.gov/bill-details/20261/HB795"
|
||
source_hash: "6c17756652c80b103becc82e99f68fb79ba1457e0267427bbb65b305f7339bce"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-va"]
|
||
---
|
||
|
||
# Virginia HB 795 (2026) — Health insurance; requirements for certain opioid antagonists.
|
||
|
||
Health insurance; requirements for certain opioid antagonists. Requires each health insurer, corporation providing health care subscription plans, and health maintenance organization whose policy, contract, or plan includes coverage for prescription drugs to include coverage for at least one other opioid antagonist used for overdose reversal dispensed pursuant to an oral, written, or standing order of a prescriber and ensure that cost-sharing for at least one opioid antagonist used for overdose reversal is included on the lowest cost tier of the insurer's, corporation's, or health maintenance organization's prescription drug formulary. The bill provides that such coverage shall be exempt from any prior authorization or step therapy requirement on coverage of benefits. As introduced, this bill was a recommendation of the Joint Commission on Health Care. This bill is identical to SB 257.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **Introduced** (filed) — [source](https://lis.blob.core.windows.net/files/1085931.PDF)
|
||
2. **Chaptered** (committee substitute) — [source](https://lis.blob.core.windows.net/files/1218014.PDF)
|
||
3. **Commerce and Labor Substitute** (committee substitute) — [source](https://lis.blob.core.windows.net/files/1201640.PDF)
|
||
4. **Labor and Commerce Substitute** (committee substitute) — [source](https://lis.blob.core.windows.net/files/1131381.PDF)
|
||
5. **Subcommittee #1 Subcommittee Substitute** (committee substitute) — [source](https://lis.blob.core.windows.net/files/1115935.PDF)
|
||
6. **Enrolled** (enrolled) — [source](https://lis.blob.core.windows.net/files/1213500.PDF)
|
||
|
||
## Votes
|
||
|
||
- Subcommittee recommends reporting with substitute — **9–0** (pass) · lower
|
||
- H VOTE: — **96–0** (pass) · lower
|
||
- Passage R — **39–0** (pass) · upper
|
||
- Constitutional reading dispensed (on 2nd reading) — **37–0** (pass) · upper
|
||
- Reconsider R — **40–0** (pass) · upper
|
||
- Reported from Finance and Appropriations — **14–0** (pass) · upper
|
||
- H VOTE: — **96–0** (pass) · lower
|
||
- Reported from Appropriations — **22–0** (pass) · lower
|
||
- Reported from Commerce and Labor with substitute — **15–0** (pass) · upper
|
||
- Subcommittee recommends reporting — **7–0** (pass) · lower
|
||
- Passage R — **40–0** (pass) · upper
|
||
- Reported from Labor and Commerce with substitute — **22–0** (pass) · lower
|
||
|
||
## Sponsors
|
||
|
||
- Atoosa R. Reaser — primary (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2026-01-13** Prefiled and ordered printed; Offered 01-14-2026 26104745D `filing, introduction`
|
||
- **2026-01-13** Referred to Committee on Health and Human Services `referral-committee`
|
||
- **2026-01-23** Fiscal Impact Statement from Department of Planning and Budget (HB795)
|
||
- **2026-01-27** Referred from Health and Human Services and referred to Labor and Commerce (Voice Vote) `referral-committee`
|
||
- **2026-01-28** Assigned HCL sub: Subcommittee #1 `referral-committee`
|
||
- **2026-02-03** House subcommittee offered
|
||
- **2026-02-03** Subcommittee recommends reporting with substitute (9-Y 0-N) `substitution`
|
||
- **2026-02-05** Reported from Labor and Commerce with substitute and referred to Appropriations (22-Y 0-N) `committee-passage`
|
||
- **2026-02-05** Committee substitute printed 26107033D-H1 `substitution`
|
||
- **2026-02-05** Assigned HAPP sub: Compensation and Retirement `referral-committee`
|
||
- **2026-02-06** Fiscal Impact Statement from Department of Planning and Budget (HB795)
|
||
- **2026-02-09** Subcommittee recommends reporting (7-Y 0-N)
|
||
- **2026-02-09** Reported from Appropriations (22-Y 0-N) `committee-passage`
|
||
- **2026-02-11** Read first time `reading-1`
|
||
- **2026-02-12** Read second time `reading-2`
|
||
- **2026-02-12** committee substitute agreed to `substitution`
|
||
- **2026-02-12** Engrossed by House - committee substitute `substitution`
|
||
- **2026-02-13** Read third time and passed House (96-Y 0-N 0-A) `passage, reading-3`
|
||
- **2026-02-16** Constitutional reading dispensed (on 1st reading)
|
||
- **2026-02-16** Referred to Committee on Commerce and Labor `referral-committee`
|
||
- **2026-03-09** Reported from Commerce and Labor with substitute and rereferred to Finance and Appropriations (15-Y 0-N) `committee-passage`
|
||
- **2026-03-09** Senate committee offered
|
||
- **2026-03-09** Committee substitute printed 26109503D-S1 `substitution`
|
||
- **2026-03-09** Reported from Finance and Appropriations (14-Y 0-N) `committee-passage`
|
||
- **2026-03-10** Fiscal Impact Statement from Department of Planning and Budget (HB795)
|
||
- **2026-03-10** Rules suspended
|
||
- **2026-03-10** Constitutional reading dispensed (on 2nd reading) (37-Y 0-N 0-A)
|
||
- **2026-03-10** Passed by for the day (Voice Vote)
|
||
- **2026-03-11** Read third time `reading-3`
|
||
- **2026-03-11** Commerce and Labor Substitute agreed to
|
||
- **2026-03-11** Engrossed by Senate - committee substitute `substitution`
|
||
- **2026-03-11** Passed Senate with substitute Block Vote (39-Y 0-N 0-A) `passage`
|
||
- **2026-03-11** Reconsideration of Senate passage agreed to by Senate (40-Y 0-N 0-A)
|
||
- **2026-03-11** Passed Senate with substitute Block Vote (40-Y 0-N 0-A) `passage`
|
||
- **2026-03-12** Senate substitute agreed to by House (96-Y 0-N 0-A) `substitution`
|
||
- **2026-03-30** Enrolled `enrolled`
|
||
- **2026-03-30** Bill text as passed House and Senate (HB795ER) `passage`
|
||
- **2026-03-30** Signed by President `passage`
|
||
- **2026-03-31** Signed by Speaker `passage`
|
||
- **2026-03-31** Enrolled Bill communicated to Governor on March 31, 2026 `enrolled, executive-receipt`
|
||
- **2026-03-31** Governor's Action Deadline 11:59 p.m., April 13, 2026 `executive-receipt`
|
||
- **2026-04-01** Fiscal Impact Statement from Department of Planning and Budget (HB795)
|
||
- **2026-04-08** Approved by Governor-Chapter 423 (effective 7/1/2026) `executive-signature`
|
||
- **2026-04-08** Acts of Assembly Chapter text (CHAP0423)
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/7977c5bc-31ee-41c0-9783-29e0ea63e355`. Confidence: reported (aggregated from official Virginia legislature records).
|
||
|